Skip to main content

Language Development Disorders

0
Pipeline Programs
2
Companies
2
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

Karla Therapeutics
Karla TherapeuticsFrance - Saint-Beauzire
1 program
Language InterventionN/A1 trial
Active Trials
NCT04775199Completed32Est. Aug 2023
Human BioSciences
Human BioSciencesWV - Martinsburg
1 program
Video Interaction ProjectN/A1 trial
Active Trials
NCT00212576Completed675Est. Dec 2017

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Karla TherapeuticsLanguage Intervention
Human BioSciencesVideo Interaction Project

Clinical Trials (2)

Total enrollment: 707 patients across 2 trials

NCT04775199Karla TherapeuticsLanguage Intervention

Improving STEM Outcomes for Young Children With Language Learning Disabilities Via Telehealth

Start: Jan 2021Est. completion: Aug 202332 patients
N/ACompleted
NCT00212576Human BioSciencesVideo Interaction Project

Promoting Early School Readiness in Primary Health Care

Start: Nov 2005Est. completion: Dec 2017675 patients
N/ACompleted

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

2 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.